Please use this identifier to cite or link to this item:
http://hdl.handle.net/10400.17/2499| Title: | Undetectable Levels of CSF Amyloid-β Peptide in a Patient with 17β-Hydroxysteroid Dehydrogenase Deficiency |
| Author: | Ortez, C Villar, C Fons, C Duarte, ST Pérez, A García-Villoria, J Ribes, A Ormazábal, A Casado, M Campistol, Jaume Vilaseca, MA García-Cazorla, A |
| Keywords: | 17-Hydroxysteroid Dehydrogenases Amyloid beta-Peptides Biomarkers Brain Diseases, Metabolic, Inborn Child, Preschool Fatal Outcome Genes, X-Linked Humans Male HDE NEU PED |
| Issue Date: | 2011 |
| Publisher: | IOS Press |
| Citation: | J Alzheimers Dis. 2011;27(2):253-7 |
| Abstract: | 17β-hydroxysteroid dehydrogenase 10 (HSD10) deficiency is a rare X-linked inborn error of isoleucine catabolism. Although this protein has been genetically implicated in Alzheimer's disease pathogenesis, studies of amyloid-β peptide (Aβ) in patients with HSD10 deficiency have not been previously reported. We found, in a severely affected child with HSD10 deficiency, undetectable levels of Aβ in the cerebrospinal fluid, together with low expression of brain-derived neurotrophic factor, α-synuclein, and serotonin metabolites. Confirmation of these findings in other patients would help elucidating mechanisms of synaptic dysfunction in this disease, and highlight the role of Aβ in both early and late periods of life. |
| Peer review: | yes |
| URI: | http://hdl.handle.net/10400.17/2499 |
| DOI: | 10.3233/JAD-2011-110647 |
| Appears in Collections: | NEU PED - Artigos |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| J Alzheimer Dis 2011_27_253.pdf | 262,39 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.












